6 g twice daily) for six months (94), required less additional therapy and had improved bronchial hyperreactivity with a reduction in eosinophil count and total IgE, IL-4, IL-5, TNF-, and airway inflammatory lipid mediators such as Cys-LT, LTb4 and 8-isoprostanes with no significant changes in IL-10 and IFN-, compared to the group with standard pharmacotherpay alone (94)
Potential peptide health benefits depend on the amino acid sequence, which is how researchers identify and categorize the different peptide types
Yes, compounded GLP-1 drugs are not FDA-approved and can vary in quality, safety, and effectiveness
It enhances glucose-dependent insulin secretion (meaning it prompts insulin release primarily when blood sugar is elevated), slows gastric emptying so a meal leaves the stomach more gradually, and acts on appetite centers in the brain to promote a feeling of fullness